Showing results (1-10 of 83) with videos related to
Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Tumor-suppressor p53: implications for tumor development and prognosisD G Kirsch, M B KastanCancer Research|October 23, 1997
p53 does not repress hypoxia-induced transcription of the vascular endothelial growth factor geneF Agani, D G Kirsch, S L Friedman, et al.Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|August 1, 1996
Signalling to p53: where does it all start?M B KastanScience (New York, N.Y.)|January 7, 1998
Conversion of Bcl-2 to a Bax-like death effector by caspasesE H Cheng, D G Kirsch, R J Clem, et al.Cold Spring Harbor Symposia on Quantitative Biology|July 28, 2006
The ATM-dependent DNA damage signaling pathwayR Kitagawa, M B KastanAdvances in Cancer Research|October 23, 2001
ATM: genome stability, neuronal development, and cancer cross pathsY Shiloh, M B KastanGenes & Development|December 16, 1998
Defective potassium currents in ataxia telangiectasia fibroblastsN Rhodes, T D'Souza, C D Foster, et al.Environmental Health Perspectives|December 1, 1993
Control of G1 arrest after DNA damageM B Kastan, S J KuerbitzNature Cell Biology|January 9, 2001
Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1D Q Yang, M B KastanAdvances in Cancer Research|January 1, 1997
p53 and ATM: cell cycle, cell death, and cancerS E Morgan, M B KastanPageof 9